Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors

{
  "signal_id": "db953e32-579a-673e-8765-d2bedd17577f",
  "signal_type": "news",
  "signal_subtype": "leaves",
  "detected_at": "2026-09-16T12:30:00+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/09/16/3363164/0/en/autonomix-medical-appoints-former-medtronic-chief-regulatory-counsel-sandra-cohen-kalter-to-board-of-directors.html",
    "title": "Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors",
    "contact": "Sandra Cohen Kalter",
    "excerpt": "Appointment adds more than four decades of MedTech leadership, FDA regulatory and strategic transaction experience, including work supporting renal denervation and other category-defining technologies THE WOODLANDS, TX, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the appointment of Sandra Cohen Kalter, former Vice President and Chief Regulatory Counsel of Medtronic plc (Medtronic) as a Board Member for Autonomix. Ms. Kalter brings more than four decades of experience across the medical device and healthcare industries, including extensive senior-level experience at Medtronic, one of the world’s largest and most diversified medical technology companies. During her tenure at Medtronic, she played a key role in regulatory, clinical and strategic initiatives spanning multiple business units and oversaw due diligence and integration activities associated with more than 27 acquisitions. Her Medtronic experience includes supporting some of the company’s most significant and innovative technologies, including the Symplicity Spyral ™ Renal Denervation system, Evolut ™ TAVR platform, Micra ™ Transcatheter Pacing System, and PulseSelect ™ Pulsed Field Ablation system. Her experience also includes involvement with the...",
    "summary": "Sandra Cohen Kalter, former Vice President and Chief Regulatory Counsel of Medtronic, has left the company and joined the board of Autonomix Medical.",
    "planning": false,
    "image_url": "https://ml.globenewswire.com/Resource/Download/e4c56b80-ba6c-47c0-8882-cab1cbe71f32",
    "job_title": "Vice President and Chief Regulatory Counsel",
    "confidence": 0.9,
    "published_at": "2026-09-16T12:30:00Z",
    "job_title_tags": [
      "directors",
      "management"
    ],
    "article_sentence": "Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the appointment of Sandra Cohen Kalter, former Vice President and Chief Regulatory Counsel of Medtronic plc (Medtronic) as a Board Member for Autonomix."
  }
}

curl https://signals.autobound.ai/v1/signals/db953e32-579a-673e-8765-d2bedd17577f \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medtronic.com","limit":20}'